|
|||||
|
|
New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United States |
|
| Authors: | Karl Kieburtz MD Russell Katz MD C. Warren Olanow MD |
| Affiliation: | 1. Clintrex LLC, Sarasota, Florida, USA;2. Department of Neurology, University of Rochester, Rochester, New York, USA;3. Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA |
| Abstract: | |
| Keywords: | |